Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for perioperative opioid reduction in ambulatory surgery
NCT06717672Phase 3Completed
- Sponsor
- Liaquat National Hospital & Medical College
- Start
- Nov 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Liaquat National Hospital & Medical College. Started Nov 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06717672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717672.